Skip to search.
 TSX Up 0.47% TSX Ventures Up 0.38%

NeurogesX, Inc. (NGSX)

-Other OTC
0.00 0.00(0.00%) Sep 2, 10:16AM EDT
Add to Portfolio
Prev Close:0.00
Open:0.00
Bid:N/A
Ask:N/A
1y Target Est:1.00
Beta:-8.44778
Next Earnings Date:N/A
Day's Range:0.00 - 0.00
52wk Range:0.00 - 0.02
Volume:20,000
Avg Vol (3m):10,302
Market Cap:143.33k
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for NGSX at this time.

Comparison

Symbol% ChgMkt Cap
NGSX 0.00%143.33k
LLYUp 2.52%86.64B
ENDPUp 2.01%15.61B
PFEUp 1.95%197.17B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):0.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NeurogesX, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel non-opioid, pain management therapies to address unmet medical needs. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback